deltatrials
Completed PHASE1 INTERVENTIONAL 3-arm NCT03289234

Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Hepatic Impairment

A Multi-Center, Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics of MCI-186 in Subjects With Mild or Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic Function

Sponsor: Tanabe Pharma Corporation

Conditions Healthy Hepatic Impairment
Interventions MCI-186
Updated 12 times since 2017 Last updated: Dec 15, 2025 Started: Nov 16, 2016 Primary completion: Jul 20, 2018 Completion: Jul 24, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Healthy and Hepatic Impairment, this trial is completed. The trial is conducted by Tanabe Pharma Corporation and has accumulated 12 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Oct 2017 – ~Jun 2018 · 8 months · monthly snapshotRecruiting~Jun 2018 – ~Dec 2018 · 6 months · monthly snapshotRecruiting~Dec 2018 – ~Mar 2020 · 15 months · monthly snapshotCompleted~Mar 2020 – ~Jan 2021 · 10 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~May 2023 · 4 months · monthly snapshotCompleted~May 2023 – ~Jul 2024 · 14 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Jan 2026 · 16 months · monthly snapshotCompleted~Jan 2026 – ~Feb 2026 · 31 days · monthly snapshotCompleted~Feb 2026 – present · 5 months · monthly snapshotCompleted

Change History

12 versions recorded

  1. Feb 2026 — Present [monthly]

    Completed PHASE1

  2. Jan 2026 — Feb 2026 [monthly]

    Completed PHASE1

  3. Sep 2024 — Jan 2026 [monthly]

    Completed PHASE1

  4. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  5. May 2023 — Jul 2024 [monthly]

    Completed PHASE1

▶ Show 7 earlier versions

  1. Jan 2023 — May 2023 [monthly]

    Completed PHASE1

  2. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE1

  3. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE1

  4. Mar 2020 — Jan 2021 [monthly]

    Completed PHASE1

  5. Dec 2018 — Mar 2020 [monthly]

    Completed PHASE1

    Status: Recruiting → Completed

  6. Jun 2018 — Dec 2018 [monthly]

    Recruiting PHASE1

  7. Oct 2017 — Jun 2018 [monthly]

    Recruiting PHASE1

    First recorded

Nov 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Tanabe Pharma Corporation
Data source: Tanabe Pharma Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations